Abstract
In the past four decades, the incidence of esophageal adenocarcinoma has increased by 500%, paralleled by a similar increase in the rate of death associated with this often fatal disease.1,2 This type of esophageal cancer develops from a precursor lesion known as Barrett's esophagus, a condition in which the normal squamous esophageal lining is replaced by columnar epithelium containing intestinal metaplasia. In a small subgroup of patients, Barrett's esophagus may undergo a transition from low-grade or high-grade dysplasia to esophageal adenocarcinoma.3 The current standard of care is to enroll patients with Barrett's esophagus in endoscopic surveillance programs and to . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
